Maha Hussain, MD, on Prostate Cancer: Results From the PROSPER Trial

2018 Genitourinary Cancers Symposium
Tweet this page

Maha Hussain, MD, of Northwestern University, discusses phase III findings on enzalutamide in men with nonmetastatic castration-resistant prostate cancer (Abstract 3).

Advertisement

Advertisement



Advertisement